Mike Dowell Discusses Need for Compliance Plans in Light of DEA Controlled Substance Compliance Inspections and Audits
In The News | 1 min read
Feb 12, 2020
Hinshaw partner Mike Dowell authored a two part Compliance Today article titled "DEA Inspections and Audits Warrant Compliance Plan." In Part 1, Dowell outlined the Controlled Substances Act (CSA)—which is enforced by the Drug Enforcement Administration (DEA)—the mission of the DEA, and its response to the opioid crisis. He also addresses a variety of requirements for pharmacies under the CSA, including those involving record-keeping, security, and dispensing. In Part 2, Dowell reviewed reporting requirements and issues concerning the development of a controlled substance compliance program.
Read "DEA Inspections and Audits Warrant Compliance Plan, Part 1" (PDF)
Read "DEA Inspections and Audits Warrant Compliance Plan, Part 2" (PDF)
Part One and Two of "DEA Inspections and Audits Warrant Compliance Plan" were published by Compliance Today in the November 2019 and December 2019 editions.
Related People
Related Locations
Featured Insights

Press Release
Oct 22, 2025
Hinshaw & Culbertson LLP Launches New Website and Refreshed Brand

Press Release
Sep 26, 2025
Hinshaw Recognized as a “Leader in Litigation” in the BTI Consulting Litigation Outlook 2026 Survey

Privacy, Cyber & AI Decoded Alert
Sep 23, 2025
Fall 2025 Regulatory Roundup: Top U.S. Privacy and AI Developments for Businesses to Track

Press Release
Sep 15, 2025
Hinshaw Achieves 2024–2025 Mansfield Rule Certification Plus Status

In The News
Sep 5, 2025
Jessica Riley Reflects in a Law360 Story on Lessons She Learned as a Junior Lawyer

Press Release
Aug 25, 2025
Trial Spotlight: Hinshaw Prevails in ERISA Fiduciary Fraud Case






